Therapy Equipment has been acquired by ESAB Corporation
Owner Venture Managers has sold Therapy Equipment Ltd. to ESAB Corporation.
Founded in 1983, Therapy Equipment is a regional leader in the medical gas control market for suction and oxygen equipment. The business holds strong market leadership across the UK and the portfolio includes trusted suction equipment, flowmeters and medical regulators used in healthcare facilities across the region and internationally.
Headquartered in the US, ESAB Corporation is a leading global gas control company with supplier-of-choice brands across the world for the industrial, medical and specialty gas industries.
Owner Venture Managers is a venture capital and private equity company based in the UK. It partners and invests alongside a network of sector-focused operating partners, who are highest-caliber individuals with proven track records of profit improvement performance and acquisition-led growth in the relevant industry of the target entity.
Oaklins Cavendish, based in the UK, advised on the sale of Therapy Equipment to ESAB Corporation.



James Wooster
Director, Owner Venture Managers
Talk to the deal team



Related deals
SHS has sold Spiegelberg to Luciole Medical AG
SHS and a minority co-shareholder have sold Spiegelberg GmbH to Luciole Medical AG.
Learn moreZephyr Group has acquired PK OEM Parts
Zephyr Group has acquired PK OEM Parts. With the entry of PK OEM Parts, Zephyr Group aims to achieve a consolidated turnover of approximately US$65 million in 2023. The acquisition will allow an increase in the services and product range offered to customers by leveraging the group’s know-how and logistical capabilities. Furthermore, the acquisition represents a step forward in the growth and consolidation strategy that Zephyr Group started in 2018 with the acquisition of Spanish competitor SKV.
Learn moreBaird Capital invests in Freemarket
Baird Capital has completed a growth capital investment in Freemarket. The investment supports Freemarket’s continuing fast growth and international expansion, as well as providing a partial cash-out to existing shareholders.
Learn more